1. Home
  2. WVE vs NGD Comparison

WVE vs NGD Comparison

Compare WVE & NGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$16.11

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo New Gold Inc.

NGD

New Gold Inc.

HOLD

Current Price

$8.84

Market Cap

5.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
NGD
Founded
2012
N/A
Country
Singapore
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
5.3B
IPO Year
2015
2004

Fundamental Metrics

Financial Performance
Metric
WVE
NGD
Price
$16.11
$8.84
Analyst Decision
Strong Buy
Buy
Analyst Count
16
2
Target Price
$29.44
$8.75
AVG Volume (30 Days)
13.6M
16.1M
Earning Date
11-10-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
1232.42
EPS
N/A
0.31
Revenue
$109,230,000.00
$1,242,200,000.00
Revenue This Year
N/A
$62.14
Revenue Next Year
$31.09
$57.44
P/E Ratio
N/A
$26.51
Revenue Growth
103.75
44.19
52 Week Low
$5.28
$2.43
52 Week High
$21.73
$8.85

Technical Indicators

Market Signals
Indicator
WVE
NGD
Relative Strength Index (RSI) 63.98 67.73
Support Level $15.23 $7.95
Resistance Level $17.41 $8.85
Average True Range (ATR) 1.83 0.50
MACD 0.22 0.05
Stochastic Oscillator 61.52 88.25

Price Performance

Historical Comparison
WVE
NGD

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About NGD New Gold Inc.

New Gold Inc participates in the development and operation of intermediate mining properties. The company has a portfolio of two primary assets which are also its operating segments: the Rainy River Mine and the New Afton Mine in Canada. The company also owns the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of gold, copper, and silver.

Share on Social Networks: